X

Pochiraju Industries Ltd. Stock Analysis

Small Cap
Evaluated by 284 users | BSE: 532803 | NSE: POCHIRAJU |
Floriculture
The company was originally incorporated as Pochiraju Flori-Tech Limited on May 4, 1995 with Registrar of Companies Tamil Nadu, Chennai. The certificate for commencement of business was received on June 5, 1995. The name of the company was changed to Pochiraju Industries Ltd. and fresh...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 13.52%11.56%11.3%5.68%8.6%3.24%-29.73%-29.46%-7.09%-4.63%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 43.355.472.41091201399.7000
Y-o-Y Gr. Rt.-27.9%30.7%50.3%10%16.2%-93.1%-100%NANA
Adjusted EPS (Rs.) 6.286.27.862.755.480.61-27.38-20.15-5.84-1.99
Y-o-Y Gr. Rt.--1.3%26.8%-65%99.3%-88.9%-4588.5%NANANA
Book Value per Share (Rs.) 40.5143.8252.0553.7263.3263.9136.5323.5417.715.71
Adjusted Net Profit 11.311.714.95.210.41.2-51.8-38.1-11.1-3.8
Net Op. Cash Flow (Rs. Cr.) 12.311.713.37.52.645.9-0.1000
Debt to Cash Flow from Ops 0.151.132.24.0715.381.06-540.43-10,176.34-77,111.15-97,118.37
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Pochiraju Industries Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%-100%-100%NA
Adjusted EPS -188%-181.7%NANA
Book Value per Share -10-24.3-24.5-11.2
Share Price -14.9% -27.6% -18.2% -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 13.7312.3113.414.298.030.85-47.24-58.93-27.56-11.52
Operating Profit Margin (%) 30.1225.3223.0415.6518.576.85-412.84000
Net Profit Margin (%) 25.9621.1420.514.788.660.82-535.28000
Debt to Equity 0.030.160.30.30.340.40.71.091.451.63
Working Capital Days 224180148122171149890000
Cash Conversion Cycle 193144118100132100525000
Entity Percentage Holding
Promoters 33.44%
Institutions 1.37%
Non-Institutions 65.19%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Pochiraju Industries's performance infers:

Pochiraju Industries earnings have declined by -181.7%, whereas share price has depreciated -27.6% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Pochiraju Industries share prices over the last 10 years. Here is what we found out:

Pochiraju Industries share price has depreciated -17.9% annually over the past ten years.

The company was originally incorporated as Pochiraju Flori-Tech Limited on May 4, 1995 with Registrar of Companies Tamil Nadu, Chennai. The certificate for commencement of business was received on June 5, 1995. The name of the company was changed to Pochiraju Industries Ltd. and fresh certificate of incorporation was obtained on September 10, 2003 from Registrar of Companies, Coimbatore

The company is currently focusing on three business segments – Agri Business, Pharmaceuticals and

The company was originally incorporated as Pochiraju Flori-Tech Limited on May 4, 1995 with Registrar of Companies Tamil Nadu, Chennai. The certificate for commencement of business was received on June 5, 1995. The name of the company was changed to Pochiraju Industries Ltd. and fresh certificate of incorporation was obtained on September 10, 2003 from Registrar of Companies, Coimbatore

The company is currently focusing on three business segments – Agri Business, Pharmaceuticals and Bio-Technology & Life Sciences. The organizational structure of the company is designed for effective management of multiple business, while retaining focus on each one of them.

Pharmapil is the Pharma Division of PIL, operating its range of pharmaceutical formulations on a national level through aggressive, dynamic and committed field force of over 250 medical representatives. Pharmapil will have two divisions, the General and the Specialty divisions and market products in tablet, capsule, liquid, injectable, powder and ointment dosage forms.

Biopil is the Biotechnology Division of PIL. A state of art plant is under construction spread over 3.86 acres of land in the S. P. Biotechnology Park situated at Turkapally, Shamirpet, Hyderabad. This plant shall utilize cell fusion techniques, hybidomas recombinant DNA technology, protein engineering and structure based molecular design which are part of modern Biotechnology. The product range shall include biosimilar products, such as Erythropoietin, G-CSF, Interferon Alpha, Interferon Beta, Human Growth Hormone and Recombinant Human Insulin. Biopil will have its own in house Research and Development Laboratory attached to a Common Quality Control, Documentation and Quality Assurance Laboratory.

Agropil is the Agricultural Division of PIL. From a modest start of 3 hectare of green house, it has gradually expanded its floriculture business to 6 hectare of green house and has established its presence in domestic as well as overseas markets. It will be engaged in developing hybrid varieties and genetically modified seeds, bio-fertilizers, bio-pesticides and plant growth stimulants in agriculture

Prouct range of the company include:

Pharma Division

  • Epo
  • Docetaxel
  • Carboplatin
  • Gefitinib
  • Rituximab
  • Oxaliplatin
  • Cisplatin
  • Temozolomide
  • Trastuzimab (Herceptin)
  • Irnotecan
  • 5-Fluorouracil
  • Imatinib
  • Bevacizumab
  • Epirubicin
  • Methotrexate
  • Erlotinib
  • Cetuximab
  • Lipo-Doxorubicine,
  • Tamoxifen

Biotechnology Division

  • Anti Bacterials – Floroquinolones
  • Antibiotics – Macrolides
  • Antibiotics – Betalactums
  • Antibiotics-Injections/Tab - Betalactum & Cephalospori
  • Antifungal drugs
  • Cardiovascular Drugs
  • Antiulcerants
  • N.S.A.I.D
  • Analgesic & Antipyretic
  • Anti spasmodic
  • Proteolytic Enzyme
  • Antihistamines
  • Neutraceuticals

Agricultural Division

Recently the company grown the different varieties of roses consisting different colours such as red, yellow, pink, white, peach etc. The companys flowers and varieties are known for their quality, stem length, bud size with good foliage, free from any pest and disease.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback